Glenmark Pharmaceuticals has gained final FDA clearance for Saxagliptin Tablets, 2.5 mg and 5 mg, the generic equivalent of AstraZeneca AB’s Onglyza Tablets, 2.5 mg and 5 mg. Glenmark Pharmaceuticals in the USA will market Saxagliptin Tablets, 2.5 mg and 5 mg, in the United States. According to IQVIATM sales statistics for the 12-month period …